New kidney disease drug begins early safety testing
NCT ID NCT07231679
Summary
This early-stage study aims to find out if a new drug called IGT-303 is safe for people. It will test single and multiple doses given as shots under the skin or into a vein. Researchers will compare the drug to a placebo in about 94 healthy volunteers and people with chronic kidney disease to check for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nucleus Network
RECRUITINGHerston, Brisbane, 4006, Australia
Conditions
Explore the condition pages connected to this study.